X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Tjoapack expands into the US with the acquisition of Pharma Packaging Solutions

Content Team by Content Team
26th October 2021
in Packaging & Logistic, Press Statements
Tjoapack expands pre-filled pharma packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Tjoapack, a Netherlands-based contract packaging organisation serving the pharmaceutical industry, has acquired US-based Pharma Packaging Solutions, a leading healthcare packaging services business based in Clinton, TN. PPS provides commercial packaging and other, complementary services such as cold chain storage, stability and product retain services to a variety of pharmaceutical and medical device industry customers.

“Tjoapack’s acquisition of PPS creates an opportunity to build a new global leader in contract packaging and supply chain services for the pharmaceutical market. The acquisition supports Tjoapack’s growth strategy and is indicative of our commitment to customers,” said Dexter Tjoa, CEO of Tjoapack. “Both companies are known in the market for having a nimble, customer-centric mindset that translates into high service quality and flexibility in providing tailored solutions to complex client needs. Having operations in both the US and Europe will ensure that our customers’ products are available to patients that need them anywhere and anytime.”

Reid Lederer, President of PPS, added, “By joining Tjoapack, Pharma Packaging Solutions will have access to resources and an extended global market presence to accelerate future growth. An important benefit of the business combination will be investments by Tjoapack to enhance PPS’s operational efficiency and capabilities, including the addition of automated packaging and labeling capabilities for injectable products. Together, the two companies will emerge as a leading, trusted provider of packaging and other value-added services to healthcare industry clients around the globe.”

Tjoapack’s acquisition of PPS was funded by Ampersand Capital Partners (“Ampersand”) which first invested in the Company in 2020. With support from Ampersand, Tjoapack is nearing the completion of a major facility expansion to substantially increase packaging capacity for both oral solid and parenteral drug products.

ABOUT TJOAPACK

Founded in 1989, Tjoapack is a contract packager of medicines that provides innovative, flexible service to clients across five continents and 45 countries. With currently 19 packaging lines, the company offers primary, secondary and unit dose packaging for oral solid dose blister packs, wallets and bottles. Tjoapack also provides automated labelling and packaging of injectable products, along with complementary supply chain services. Tjoapack’s 120,000 square foot facility is strategically located near the ports of Rotterdam and Antwerp, serving as a gateway to the European market.

ABOUT PHARMA PACKAGING SOLUTIONS

Pharma Packaging Solutions was founded in 1998 as a division of Carton Services, Inc., a supplier of folding cartons to the pharmaceutical, food and consumer packaged goods industries. Operating from a 110,000 square foot facility in Clinton, TN, PPS serves a variety of healthcare industry customers with contract packaging and related services.

ABOUT AMPERSAND CAPITAL PARTNERS

Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors.

Previous Post

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Next Post

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
The UK begins the biggest ever immunization program

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In